The COVID-19 pandemic has been accompanied by SARS-CoV-2 evolution and
emergence of viral variants that have far exceeded initial expectations. Five major variants of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages have
escaped most receptor-binding domain (RBD)-targeting therapeutic neutralizing antibodies …

Mutations in the SARS-CoV-2 genome could confer resistance to pre-existing antibodies
and/or increased transmissibility. The recently emerged Omicron subvariants exhibit a …

Soon after the emergence and global spread of a new severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) Omicron lineage, BA. 1 (ref,), another Omicron lineage, BA. 2 …

The infective SARS-CoV-2 is more prone to immune escape. Presently, the significant
variants of SARS-CoV-2 are emerging in due course of time with substantial mutations …

Background Limited data are available on the effectiveness of inactivated and Ad5-nCoV
COVID-19 vaccines in real-world use—especially against Omicron variants in SARS-CoV-2 …

A full understanding of the inactivated COVID-19 vaccine-mediated antibody responses to
SARS-CoV-2 circulating variants will inform vaccine effectiveness and vaccination …

Host–pathogen interactions and pathogen evolution are underpinned by protein–protein
interactions between viral and host proteins. An understanding of how viral variants affect …

Despite the vast diversity of the antibody repertoire, infected individuals often mount
antibody responses to precisely the same epitopes within antigens. The immunological …

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages — United
States, January 2022–May 2023 | MMWR Skip directly to site content Skip directly to search …